News Lee's Pharmaceutical Holdings Limited

Equities

950 KYG5438W1116

Market Closed - Hong Kong S.E. Other stock markets 04:08:15 2024-04-18 am EDT			5-day change	1st Jan Change
1.16 ^HKD	0.00%		-1.69%	-24.18%

Mar. 26	Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	CI
Mar. 26	Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	Mar. 26	CI
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
China Grants Lee's Pharmaceutical Drug Registration for Schizophrenia-Related Agitation Treatment; Shares Rise 3%	Nov. 28	MT
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	Nov. 14	MT
Ex-dividend day for interim dividend	23-09-11	FA
Lee's Pharmaceutical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 October 2023	23-08-30	CI
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Lee's Pharmaceutical Holdings Unit's Fentanyl Inhalable Reaches Endpoints in Phase 2A Trial	23-08-22	MT
Lee's Pharmaceutical Holdings Limited Announces Phase IIa Clinical Trial of A F fentanyl Aerosol for Inhalation Conducted by Zhaoke Pharmaceutical Limited	23-08-21	CI
Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-08-21	CI
Lee’s Pharmaceutical Gets Registration Certificate for Medical Device to Treat Hypoxic Respiratory Failure	23-06-09	MT
Final dividend	23-05-24	FA
Lee's Pharmaceutical Holdings Limited Appoints Cheang Yee Wah, Eva as Independent Non-Executive Director	23-05-17	CI
Lee's Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023	23-03-30	CI
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Lee’s Pharmaceutical Holdings Warns of Plunge in 2022 Profit	23-03-21	MT
Lee's Pharmaceutical Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	23-03-20	CI
Extended Phase 2b Study for Lee's Pharmaceutical's Tafoxiparin Concludes; Shares Slip 3%	23-02-17	MT
Nine Lee's Pharma Products Included in China's National Reimbursement Drug List	23-01-19	MT
Lee's Pharmaceutical Holdings Limited Announces Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List	23-01-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lee's Pharmaceutical Holdings Limited

Equities

950

KYG5438W1116

Summary

Filters